Department of Clinical Dentistry, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.
Centre for New Antimicrobial Strategies, UiT the Arctic University of Norway, Tromsø, Norway.
J Appl Microbiol. 2021 Mar;130(3):832-842. doi: 10.1111/jam.14837. Epub 2020 Sep 17.
Antimicrobial resistance genes (ARGs) are often associated with mobile genetic elements (MGEs), which facilitate their movement within and between bacterial populations. Detection of mobility is therefore important to understand the dynamics of MGE dissemination and their associated genes, especially in resistant clinical isolates that often have multiple ARGs associated with MGEs. Therefore, this study aimed to develop an entrapment vector to capture active MGEs and ARGs in clinical isolates of Escherichia coli.
We engineered an entrapment vector, called pBACpAK, to capture MGEs in clinical E. coli isolates. It contains a cI-tetA positive selection cartridge in which the cI gene encodes a repressor that inhibits the expression of tetA. Therefore, any disruption of cI, for example, by insertion of a MGE, will allow tetA to be expressed and result in a selectable tetracycline-resistant phenotype. The pBACpAK was introduced into clinical E. coli isolates and grown on tetracycline-containing agar to select for clones with the insertion of MGEs into the entrapment vector. Several insertion sequences were detected within pBACpAK, including IS26, IS903B and ISSbo1. A novel translocatable unit (TU), containing IS26 and dfrA8 was also captured, and dfrA8 was shown to confer trimethoprim resistance when it was cloned into E. coli DH5α.
The entrapment vector, pBACpAK was developed and shown to be able to capture MGEs and their associated ARGs from clinical E. coli isolates. We have captured, for the first time, a TU encoding antibiotic resistance.
This is the first time that a TU and associated resistance gene has been captured from clinical E. coli isolates using an entrapment vector. The pBACpAK has the potential to be used not only as a tool to capture MGEs in clinical E. coli isolates, but also to study dynamics, frequency and potentiators of mobility for MGEs.
抗菌药物耐药基因 (ARGs) 通常与移动遗传元件 (MGEs) 相关,这有助于它们在细菌种群内和种群间的移动。因此,检测移动性对于了解 MGE 传播及其相关基因的动态非常重要,特别是在具有多种与 MGE 相关的 ARGs 的耐药临床分离株中。因此,本研究旨在开发一种捕获载体,以捕获大肠杆菌临床分离株中的活性 MGE 和 ARGs。
我们设计了一种称为 pBACpAK 的捕获载体,用于捕获临床大肠杆菌分离株中的 MGE。它包含一个 cI-tetA 正选择盒,其中 cI 基因编码一种阻遏物,抑制 tetA 的表达。因此,任何对 cI 的破坏,例如插入 MGE,将允许 tetA 表达,并导致可选择的四环素抗性表型。将 pBACpAK 引入临床大肠杆菌分离株中,并在含有四环素的琼脂上生长,以选择插入 MGE 到捕获载体中的克隆。在 pBACpAK 中检测到几个插入序列,包括 IS26、IS903B 和 ISSbo1。还捕获了一个新的可转移单元 (TU),其中包含 IS26 和 dfrA8,当将其克隆到大肠杆菌 DH5α 中时,dfrA8 显示出对甲氧苄啶的抗性。
开发了捕获载体 pBACpAK,并证明能够从临床大肠杆菌分离株中捕获 MGE 及其相关的 ARGs。我们首次捕获了一个编码抗生素耐药性的 TU。
这是首次使用捕获载体从临床大肠杆菌分离株中捕获 TU 和相关耐药基因。pBACpAK 有可能不仅用作捕获临床大肠杆菌分离株中 MGE 的工具,还可用于研究 MGE 移动性的动态、频率和增强剂。